Cytek Biosciences (CTKB) Change in Receivables (2020 - 2026)
Cytek Biosciences posted quarterly Change in Receivables of -$9.6 million for Q1 2026, down 49.56% year-on-year from -$19.1 million in Q1 2025, and down 256.93% on a QoQ basis from $6.1 million in Q4 2025.
Cytek Biosciences (CTKB) has 7 years of Change in Receivables data on file, last reported at -$9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 49.56% year-over-year to -$9.6 million; the trailing twelve-month figure through Mar 2026 stood at -$3.6 million (down 210.89% YoY), and the FY2025 full-year result was -$368000.0, down 106.78% from the prior year.
- Change in Receivables for Q1 2026 stood at -$9.6 million, down from $6.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.3 million in Q4 2024 and bottomed at -$9.6 million in Q1 2026.
- The 5-year median for Change in Receivables is $1.0 million (2022), against an average of $1.3 million.
- The widest annual swing landed in 2023, when Change in Receivables sank 683.33%; it then jumped 3647.15% in 2024.
- A 5-year view of Change in Receivables shows it stood at $8.0 million in 2022, then tumbled by 103.3% to -$263000.0 in 2023, then surged by 3647.15% to $9.3 million in 2024, then slumped by 34.12% to $6.1 million in 2025, then tumbled by 256.93% to -$9.6 million in 2026.
- The last three Change in Receivables figures came in at -$9.6 million (Q1 2026), $6.1 million (Q4 2025), and $587000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -9.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.65 Mn |
| Mar 31, 2026 | -9.65 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Sep 30, 2025 | 587,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Mar 31, 2025 | -6.45 Mn |
| Mar 31, 2025 | -6.45 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | -263,000.00 |
| Dec 31, 2023 | -263,000.00 |
| Sep 30, 2023 | 6.85 Mn |
| Sep 30, 2023 | 6.85 Mn |
| Jun 30, 2023 | 6.80 Mn |
| Jun 30, 2023 | 6.80 Mn |
| Mar 31, 2023 | -6.06 Mn |
| Mar 31, 2023 | -6.06 Mn |
| Dec 31, 2022 | 7.96 Mn |
| Dec 31, 2022 | 7.96 Mn |
| Sep 30, 2022 | 3.82 Mn |
| Sep 30, 2022 | 3.82 Mn |
| Jun 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 6.93 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 720,000.00 |
| Dec 31, 2021 | 720,000.00 |
| Sep 30, 2021 | 5.59 Mn |
| Sep 30, 2021 | 5.59 Mn |
| Jun 30, 2021 | 8.29 Mn |
| Jun 30, 2021 | 8.29 Mn |
| Mar 31, 2021 | -2.24 Mn |
| Mar 31, 2021 | -2.24 Mn |
| Dec 31, 2020 | -1.15 Mn |
| Dec 31, 2020 | -1.15 Mn |
| Sep 30, 2020 | 4.91 Mn |
| Sep 30, 2020 | 4.91 Mn |